Kevin A. Lobo is a business executive in the orthopedic industry.
Lobo was born in India and raised in Montreal, Canada. He married Shazie Zaman, whom he met in college. They have two children. Lobo speaks French and English, as well as a little bit of Konkani and Hindi; his wife speaks Urdu, descending from both Bangladeshi and Pakistani origins.
Lobo was appointed to the roles of Chief Executive Officer and Group President of Stryker Corporation in 2012, following the sudden departure of Stephen Macmillan. He became a Director of the Parker-Hannifin Corporation in 2013 and Chairman of Stryker in 2014. He sits on the Boards of: the Advanced Medical Technology Association (AdvaMed), theBusiness Leaders for Michigan and United Way for Kalamazoo/Battle Creek regions. He is also a member of the Business Roundtable.
Vis-à-vis Stryker, today Lobo spends most of his working hours in their Kalamazoo corporate offices. Very soon after he took on these leadership roles at the firm, he made a real impression, especially when he led the firm in its first acquisition in China – Trauson Holdings Co., costing $764 million. This also brought the firm more into the trauma surgeryindustry, a fast emerging market in the orthopedics field. Of the acquisition Lobo said: “That was a heavy decision and I feel very good about it. There are a lot of learnings. These are all firsts for me – my first time meeting with investors and analysts, managing and working with a board of directors, but with any new job you learn to make decisions. I'm pleased I have had the chance to speak to more than half of our employees this year around the world.”
His total compensation for the 2014 fiscal year was: $9,120,147.
Before taking on the lead role at the firm, Lobo was Group President of New Jersey-based Stryker Orthopedics and President of Orthovita Inc. Prior to that, he held executive positions at Kraft and KPMG, Unilever in Canada, at Rhone-Poulenc in Europe, and thereafter, at Johnson Johnson where he held the role of President of Medical Products.
He was also the Vice President of Finance for Consumer and Specialty Pharmaceuticals and Ortho Women's Health Urology, President at Ethicon Endo-Surgery Inc., head of Rhone-Poulenc’s Phosphate Division in the UK, supervising six manufacturing plants in an industry and country in which he had very minimal knowledge. Describing it as a “stretch assignment,” he further explains that he learned to realize that “success hinges entirely on making sure you have the right people that are engaged and focused on performance. If you do that, it doesn’t matter what industry or country you’re in, you can have success.” Ultimately he turned the business into a success, and it became one of Kalamazoo’s largest companies.
Stryker Corporation is a Fortune 500 medical technologies firm based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
In the United States, most of Stryker's products are marketed directly to doctors, hospitals and other healthcare facilities. Internationally, Stryker products are sold in over 100 countries through company-owned sales subsidiaries and branches as well as third-party dealers and distributors.